BG62887B1 - Нафтиламиди като средства, повлияващи централната нервна система - Google Patents

Нафтиламиди като средства, повлияващи централната нервна система Download PDF

Info

Publication number
BG62887B1
BG62887B1 BG100830A BG10083096A BG62887B1 BG 62887 B1 BG62887 B1 BG 62887B1 BG 100830 A BG100830 A BG 100830A BG 10083096 A BG10083096 A BG 10083096A BG 62887 B1 BG62887 B1 BG 62887B1
Authority
BG
Bulgaria
Prior art keywords
ethyl
naphthalenecarboxamide
bromo
piperazinyl
methoxy
Prior art date
Application number
BG100830A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100830A (en
Inventor
Shelly Glase
Suzanne Kesten
Lawrence WISE
Jonathan Wright
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG100830A publication Critical patent/BG100830A/xx
Publication of BG62887B1 publication Critical patent/BG62887B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
BG100830A 1994-03-24 1996-09-05 Нафтиламиди като средства, повлияващи централната нервна система BG62887B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/217,395 US5395835A (en) 1994-03-24 1994-03-24 Naphthalamides as central nervous system agents
PCT/US1995/001974 WO1995025727A1 (fr) 1994-03-24 1995-02-16 Naphtylamides comme agents actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
BG100830A BG100830A (en) 1997-10-31
BG62887B1 true BG62887B1 (bg) 2000-10-31

Family

ID=22810896

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100830A BG62887B1 (bg) 1994-03-24 1996-09-05 Нафтиламиди като средства, повлияващи централната нервна система

Country Status (23)

Country Link
US (1) US5395835A (fr)
EP (1) EP0751939B9 (fr)
JP (1) JP3771581B2 (fr)
KR (1) KR100366175B1 (fr)
AT (1) ATE219068T1 (fr)
AU (1) AU683358B2 (fr)
BG (1) BG62887B1 (fr)
CZ (1) CZ284377B6 (fr)
DE (1) DE69527053T2 (fr)
DK (1) DK0751939T5 (fr)
ES (1) ES2178668T4 (fr)
FI (1) FI113370B (fr)
HU (1) HUT76058A (fr)
MX (1) MX9602517A (fr)
NO (1) NO306779B1 (fr)
NZ (1) NZ281824A (fr)
PH (1) PH31335A (fr)
PL (1) PL181270B1 (fr)
PT (1) PT751939E (fr)
RO (1) RO117452B1 (fr)
RU (1) RU2157370C2 (fr)
WO (1) WO1995025727A1 (fr)
ZA (1) ZA952382B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
PT732332E (pt) * 1995-03-17 2002-06-28 Aventis Pharma Inc Benzotienilpiperazinas substituidas sua utilizacao como medicamentos e processos para a sua preparacao
FR2738569B1 (fr) * 1995-09-12 1997-11-28 Pf Medicament Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
US5659033A (en) * 1995-09-13 1997-08-19 Neurogen Corporation N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques
US5710274A (en) * 1996-02-28 1998-01-20 Neurogen Corporation N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
US5763609A (en) * 1996-03-21 1998-06-09 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands
US5703235A (en) * 1996-03-21 1997-12-30 Neurogen Corporation N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
US5703083A (en) * 1996-04-15 1997-12-30 Neurogen Corporation N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
US5703237A (en) * 1996-04-18 1997-12-30 Neurogen Corporation N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
US5688950A (en) * 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
US5892041A (en) * 1996-08-12 1999-04-06 Neurogen Corporation Fused indolecarboxamides: dopamine receptor subtype specific ligands
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) * 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
WO1999059973A1 (fr) * 1998-05-15 1999-11-25 Guilford Pharmaceuticals Inc. Composes de carboxamide, compositions et methodes d'inhibition de l'activite de type poly(adp-ribose) polymerase (parp)
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
EP1272187B1 (fr) * 2000-03-27 2008-07-30 Abbott GmbH & Co. KG Ligands du recepteur d3 de la dopamine destines au traitement de la dependance
WO2001090077A1 (fr) 2000-05-19 2001-11-29 Guilford Pharmaceuticals, Inc. Derives de sulfonamide et de carbamide de 6(5h) phenanthridinones et utilisations de ceux-ci
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6545011B2 (en) 2000-07-13 2003-04-08 Guilford Pharmaceuticals Inc. Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses
WO2002066469A2 (fr) * 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Nouveaux derives heterocycliques d'amides et leur utilisation comme ligands du recepteur de la dopamine d3
ES2275853T3 (es) * 2001-02-16 2007-06-16 Aventis Pharmaceuticals Inc. Derivados heterociclicos de urea y su uso como ligandos de receptores de dopamina d3.
EP1509213A2 (fr) * 2002-05-23 2005-03-02 Abbott Laboratories Acetamides et benzamides utilises dans le traitement d'une dysfonction sexuelle
EP1870405A1 (fr) * 2006-06-22 2007-12-26 Bioprojet (Aza)cyclohexanes carbonylées comme ligands du récepteur D3 de la dopamine
KR20230001660U (ko) 2022-02-08 2023-08-16 주식회사 승진피엘에스 옷걸이용 지주 고정장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1543944A (fr) * 1967-03-10 1968-10-31 Bruneau & Cie Lab Dérivés amidés de l'acide salicylique et leur préparation
US3846430A (en) * 1968-01-12 1974-11-05 Bruneau & Cie Lab 1-(2-methoxy-phenyl)-4-{8 2-(4-fluoro-benzamido)-ethyl{9 -piperazine
US4975439A (en) * 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5010078A (en) * 1988-05-24 1991-04-23 American Home Products Corporation Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them
JP2671059B2 (ja) * 1990-11-30 1997-10-29 富士レビオ株式会社 ナフトエ酸誘導体
FR2682953B1 (fr) * 1991-10-23 1995-04-21 Inst Nat Sante Rech Med Nouveaux derives de naphtamides, leur procede de preparation et leur application dans le domaine therapeutique.
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
FR2693722B1 (fr) * 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
HUT76058A (en) 1997-06-30
DE69527053D1 (de) 2002-07-18
AU683358B2 (en) 1997-11-06
HU9602605D0 (en) 1996-11-28
NZ281824A (en) 1997-10-24
FI113370B (fi) 2004-04-15
BG100830A (en) 1997-10-31
NO963996L (no) 1996-09-23
WO1995025727A1 (fr) 1995-09-28
EP0751939A1 (fr) 1997-01-08
CZ284377B6 (cs) 1998-11-11
US5395835A (en) 1995-03-07
CZ276896A3 (en) 1997-04-16
RU2157370C2 (ru) 2000-10-10
JPH09511503A (ja) 1997-11-18
EP0751939B1 (fr) 2002-06-12
DE69527053T2 (de) 2003-01-02
EP0751939B9 (fr) 2003-01-02
ES2178668T3 (es) 2003-01-01
JP3771581B2 (ja) 2006-04-26
PL316313A1 (en) 1997-01-06
RO117452B1 (ro) 2002-03-29
AU1877495A (en) 1995-10-09
NO963996D0 (no) 1996-09-23
ZA952382B (en) 1996-01-10
FI963294A (fi) 1996-08-23
DK0751939T3 (da) 2002-10-07
NO306779B1 (no) 1999-12-20
PL181270B1 (pl) 2001-07-31
PH31335A (en) 1998-07-06
KR100366175B1 (ko) 2003-04-08
FI963294A0 (fi) 1996-08-23
PT751939E (pt) 2002-11-29
ES2178668T4 (es) 2003-06-16
ATE219068T1 (de) 2002-06-15
DK0751939T5 (da) 2004-11-08
MX9602517A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
BG62887B1 (bg) Нафтиламиди като средства, повлияващи централната нервна система
CN101228138B (zh) 神经治疗吡咯化合物
JP2000504677A (ja) ５ｈｔ７レセプター・アンタゴニスト用のスルホンアミド誘導体
KR100343060B1 (ko) 벤조푸릴유도체,이의제조방법및이를함유하는약제
US20040242589A1 (en) 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
JP2012111784A (ja) 置換アリールアミン化合物および５−ｈｔ６調節因子としてのその使用
FR2686878A1 (fr) Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
JP2003534331A (ja) 置換１−アミノアルキルラクタム及びムスカリンレセプターアンタゴニストとしてのそれらの使用
CN101568520A (zh) 具有脲结构的新型n-(2-氨基苯基)苯甲酰胺衍生物
EP1631546A1 (fr) Derives indole et indoline substitues
WO2010040274A1 (fr) Nouveaux ligands de récepteurs d3 de la dopamine, leurs procédés de préparation et leurs applications
US5965560A (en) Substituted piperazines and piperidines as central nervous system agents
JP2001512113A (ja) 抗腫瘍及び抗転移剤としてのｏ−置換ヒドロキシクマラノン誘導体
EP0694536A1 (fr) Dérivés de 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one, leur préparation, et compositions pharmaceutiques les contenant
FI120400B (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit
CN1063177C (zh) 治疗偏头痛的吲哚烷基－吡啶基和嘧啶基哌嗪的1,2,5－噻二唑衍生物
GB2176785A (en) Annellated benzamide derivatives
JP2002509135A (ja) 神経細胞カルシウムチャンネルの活性の調節剤としてのアミノスルホニルベンズアミド誘導体
JPS6257606B2 (fr)
CA2180155C (fr) Naphtylamides comme agents actifs sur le systeme nerveux central
AU617094B2 (en) New indolecarboxamide derivatives as well as salts thereof, process and intermediates for preparation, application of these derivatives by way of medicinal products and compositions containing them
JPH11180979A (ja) 環状アミン誘導体
AU597727B2 (en) Aryloxy-aminoalkanes
JPS6133172A (ja) １，３−置換−２−イミダゾリジノン誘導体，胃腸運動亢進剤及びその製造方法
JPH02264780A (ja) α―アドレナリン作動性受容体拮杭剤